found high local expression of CXCL9 in the liver of a fatty liver mouse model with non-alcoholic steatohepatitis (50), suggesting a near correlation between steatohepatitis development and elevated local CXCL9 levels. Here, CXCL9 is linked to metabolic dysfunction-associated steatohepatitis.